Stay updated with breaking news from Previously Treated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Total Revenues of $2.0 Billion in 2022, Including 23 Percent Annual Increase in Total Net Product Sales to $1.7 Billion--TUKYSA Granted FDA Accelerated Approval for Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer--ADCETRIS Received Pediatric Indication with FDA Approval for Children wit...
Latest news on Cancer Treatment including updates on radiotherapy, chemotherapy, immunotherapy, funding, trials and developments.
Enhertu Approved by Health Canada as the First HER2-Directed Therapy for Patients with HER2-Low Metastatic Breast Cancer - read this article along with other careers information, tips and advice on BioSpace
Investegate announcements from AstraZeneca PLC, Enhertu recommended for EU approval in HER2-low BC
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 65 company and partner abstracts across 8 types of cancer during the upcoming American...